
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $2.8B | $3.4B | $4.2B | $4.3B | $4.2B | |
Revenue Growth (YoY) | -2.78% | 20.78% | 23.31% | 1.75% | -2.58% | |
Cost of Revenues | $1.3B | $1.7B | $2.4B | $2.2B | $1.8B | |
Gross Profit | $1.5B | $1.7B | $1.8B | $2.1B | $2.4B | |
Gross Profit Margin | 54.33% | 49.77% | 43.05% | 48.14% | 57.92% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $4.2M | -$4.3M | $31M | $62.6M | $48.2M | |
Operating Expenses | $708.6M | $790.8M | $887.9M | $991.1M | $1.1B | |
Operating Income | $824.1M | $905M | $921M | $1.1B | $1.4B | |
Net Interest Expenses | $81.5M | $81.4M | $100M | $130.1M | $167.7M | |
EBT. Incl. Unusual Items | $746.8M | $819.3M | $851.9M | $999.6M | $1.2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $145.4M | $153.7M | $77.5M | $113.8M | $192.9M | |
Net Income to Company | $601.4M | $665.6M | $774.4M | $885.9M | $1B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $601.4M | $665.6M | $774.4M | $885.9M | $1B | |
Basic EPS (Cont. Ops) | $4.89 | $5.12 | $5.61 | $6.10 | $6.83 | |
Diluted EPS (Cont. Ops) | $4.89 | $5.12 | $5.60 | $6.10 | $6.83 | |
Weighted Average Basic Share | $122.8M | $129.8M | $137.8M | $145.1M | $152.5M | |
Weighted Average Diluted Share | $122.9M | $129.8M | $138.1M | $145.2M | $152.7M | |
EBITDA | $1.3B | $1.4B | $1.5B | $1.7B | $2.1B | |
EBIT | $831.3M | $902.9M | $954.7M | $1.1B | $1.4B | |
Revenue (Reported) | $2.8B | $3.4B | $4.2B | $4.3B | $4.2B | |
Operating Income (Reported) | $824.1M | $905M | $921M | $1.1B | $1.4B | |
Operating Income (Adjusted) | $831.3M | $902.9M | $954.7M | $1.1B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.3B | $1.6B | $1.5B | $1.6B | $2B | |
Revenue Growth (YoY) | 34.92% | 25.07% | -6.6% | 6.9% | 18.41% | |
Cost of Revenues | $730.2M | $1B | $860.9M | $824.2M | $1B | |
Gross Profit | $588.9M | $615.1M | $680M | $823M | $938M | |
Gross Profit Margin | 44.64% | 37.28% | 44.13% | 49.97% | 48.09% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $2.8M | $5.2M | $17.4M | $16.7M | $24.2M | |
Operating Expenses | $207.1M | $230M | $257.4M | $272M | $309M | |
Operating Income | $381.8M | $385.1M | $422.6M | $551M | $628.9M | |
Net Interest Expenses | $26.1M | $28.9M | $37.4M | $55.4M | $50M | |
EBT. Incl. Unusual Items | $358.5M | $361.4M | $402.7M | $512.2M | $603.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61.8M | $36.4M | $45M | $80.2M | $117.5M | |
Net Income to Company | $296.8M | $325M | $357.7M | $432M | $485.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $296.8M | $325M | $357.7M | $432M | $485.6M | |
Basic EPS (Cont. Ops) | $2.30 | $2.37 | $2.48 | $2.85 | $3.05 | |
Diluted EPS (Cont. Ops) | $2.30 | $2.37 | $2.48 | $2.85 | $3.03 | |
Weighted Average Basic Share | $129.2M | $136.8M | $143.9M | $151.3M | $159.2M | |
Weighted Average Diluted Share | $129.2M | $137.3M | $144M | $151.3M | $160.4M | |
EBITDA | $503.3M | $523.7M | $588.4M | $732.8M | $835.9M | |
EBIT | $384.6M | $390.3M | $440M | $567.7M | $653.1M | |
Revenue (Reported) | $1.3B | $1.6B | $1.5B | $1.6B | $2B | |
Operating Income (Reported) | $381.8M | $385.1M | $422.6M | $551M | $628.9M | |
Operating Income (Adjusted) | $384.6M | $390.3M | $440M | $567.7M | $653.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $3.8B | $4.6B | $4.1B | $4.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.5B | $2.1B | $2.6B | $1.8B | $1.9B | |
Gross Profit | $1.7B | $1.7B | $2B | $2.3B | $2.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $11.2M | $720K | $55.6M | $58.5M | $62.4M | |
Operating Expenses | $750.2M | $831.5M | $948.2M | $1B | $1.1B | |
Operating Income | $920.5M | $885.3M | $1B | $1.3B | $1.5B | |
Net Interest Expenses | $80.2M | $82.1M | $125.4M | $163.3M | $163.4M | |
EBT. Incl. Unusual Items | $851.5M | $804M | $934.1M | $1.2B | $1.4B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $154M | $78.6M | $104.3M | $169.1M | $255.7M | |
Net Income to Company | $697.6M | $725.3M | $829.7M | $999.6M | $1.1B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $697.6M | $725.3M | $829.7M | $999.6M | $1.1B | |
Basic EPS (Cont. Ops) | $5.50 | $5.36 | $5.83 | $6.67 | $7.21 | |
Diluted EPS (Cont. Ops) | $5.50 | $5.36 | $5.82 | $6.67 | $7.17 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.4B | $1.4B | $1.6B | $2B | $2.3B | |
EBIT | $934.7M | $888.2M | $1.1B | $1.3B | $1.6B | |
Revenue (Reported) | $3.2B | $3.8B | $4.6B | $4.1B | $4.5B | |
Operating Income (Reported) | $920.5M | $885.3M | $1B | $1.3B | $1.5B | |
Operating Income (Adjusted) | $934.7M | $888.2M | $1.1B | $1.3B | $1.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.2B | $2.7B | $3B | $2.8B | $3.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.2B | $1.6B | $1.8B | $1.3B | $1.5B | |
Gross Profit | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | $8.9M | $13.9M | $38.6M | $34.6M | $48.8M | |
Operating Expenses | $395.8M | $436.6M | $497M | $526.2M | $584.5M | |
Operating Income | $680.6M | $661M | $743.8M | $950.1M | $1.1B | |
Net Interest Expenses | $48.1M | $48.8M | $74.1M | $107.3M | $102.9M | |
EBT. Incl. Unusual Items | $641.4M | $626.1M | $708.3M | $877.4M | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $127M | $51.9M | $78.8M | $134M | $196.9M | |
Net Income to Company | $514.4M | $574.2M | $629.5M | $743.3M | $837.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $514.4M | $574.2M | $629.5M | $743.3M | $837.4M | |
Basic EPS (Cont. Ops) | $4.01 | $4.23 | $4.40 | $4.93 | $5.30 | |
Diluted EPS (Cont. Ops) | $4.01 | $4.23 | $4.39 | $4.93 | $5.26 | |
Weighted Average Basic Share | $256.2M | $270.5M | $285.8M | $301.1M | $315.5M | |
Weighted Average Diluted Share | $256.2M | $270.9M | $285.9M | $301.1M | $318.3M | |
EBITDA | $923.5M | $936.1M | $1.1B | $1.3B | $1.5B | |
EBIT | $689.6M | $674.9M | $782.4M | $984.7M | $1.1B | |
Revenue (Reported) | $2.2B | $2.7B | $3B | $2.8B | $3.1B | |
Operating Income (Reported) | $680.6M | $661M | $743.8M | $950.1M | $1.1B | |
Operating Income (Adjusted) | $689.6M | $674.9M | $782.4M | $984.7M | $1.1B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $20.8M | $116.7M | $51.6M | $15.4M | $307.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $140.3M | $218.2M | $258.3M | $199M | $220.9M | |
Inventory | $118.8M | $193.7M | $383.8M | $280.1M | $186.5M | |
Prepaid Expenses | $40.3M | $48.8M | $58.6M | $58M | $74.8M | |
Other Current Assets | $14.5M | $2B | $2B | $33.4M | $20.1M | |
Total Current Assets | $471.3M | $2.8B | $3B | $885.8M | $1.1B | |
Property Plant And Equipment | $13.6B | $15.3B | $17.5B | $19.8B | $22.5B | |
Long-Term Investments | $104M | $108.1M | $96M | $104.6M | $110.6M | |
Goodwill | $731.3M | $731.3M | $731.3M | $731.3M | $731.3M | |
Other Intangibles | -- | -- | -- | $92.2M | $82.8M | |
Other Long-Term Assets | $23.4M | $27.7M | $21M | $23.3M | $30.3M | |
Total Assets | $15.4B | $19.6B | $22.2B | $22.5B | $25.2B | |
Accounts Payable | $141.1M | $224.9M | $258.5M | $218.2M | $341.9M | |
Accrued Expenses | $106.2M | $152.8M | $139.1M | $153.2M | $190.4M | |
Current Portion Of Long-Term Debt | -- | $2.4B | $2.4B | $253.4M | $9.9M | |
Current Portion Of Capital Lease Obligations | $35.9M | $38.1M | $38.6M | $35.8M | $34.3M | |
Other Current Liabilities | $154.8M | $275.2M | $290.5M | $305.1M | $254.3M | |
Total Current Liabilities | $782.4M | $3.5B | $3.6B | $1.4B | $1.2B | |
Long-Term Debt | $4.5B | $4.9B | $5.8B | $6.6B | $7.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $8.6B | $11.7B | $12.8B | $11.6B | $13B | |
Common Stock | $629K | $662K | $704K | $742K | $776K | |
Other Common Equity Adj | -$57.6M | $69.8M | $369.1M | $518.5M | $465.7M | |
Common Equity | $6.8B | $7.9B | $9.4B | $10.9B | $12.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $6.8B | $7.9B | $9.4B | $10.9B | $12.2B | |
Total Liabilities and Equity | $15.4B | $19.6B | $22.2B | $22.5B | $25.2B | |
Cash and Short Terms | $20.8M | $116.7M | $51.6M | $15.4M | $307.3M | |
Total Debt | $4.5B | $7.3B | $8.1B | $6.9B | $7.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $865.3M | $582.5M | $95.2M | $262.5M | $543.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $469.6M | $565.2M | $523.7M | $596.4M | $660.6M | |
Inventory | $50M | $96.3M | $183.5M | $144.1M | $97.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $235.5M | $2.3B | $270.7M | $428.1M | $288.3M | |
Total Current Assets | $1.6B | $3.5B | $1.1B | $1.4B | $1.6B | |
Property Plant And Equipment | $14B | $16.1B | $18.4B | $20.8B | $23.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $731.3M | $731.3M | $731.3M | $731.3M | $731.3M | |
Other Intangibles | -- | -- | -- | $87.3M | $78.9M | |
Other Long-Term Assets | -- | -- | $1.1B | $939.1M | $946.7M | |
Total Assets | $19.4B | $21.3B | $21.3B | $24B | $27B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | $9.6M | $20.1M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $607.5M | $653M | $746.5M | $677.7M | $733.2M | |
Total Current Liabilities | $871.3M | $3.2B | $1.1B | $1.1B | $1.2B | |
Long-Term Debt | $7.3B | $5.8B | $6.6B | $7.5B | $8.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.6B | $12.3B | $11.1B | $12.4B | $13.8B | |
Common Stock | $653K | $695K | $722K | $754K | $794K | |
Other Common Equity Adj | $140.5M | $145.6M | $361M | $495.7M | $476.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $7.8B | $9B | $10.2B | $11.6B | $13.1B | |
Total Liabilities and Equity | $19.4B | $21.3B | $21.3B | $24B | $27B | |
Cash and Short Terms | $865.3M | $582.5M | $95.2M | $262.5M | $543.5M | |
Total Debt | $7.3B | $8B | $6.6B | $7.5B | $8.5B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $601.4M | $665.6M | $774.4M | $885.9M | $1B | |
Depreciation & Amoritzation | $429.8M | $478M | $535.7M | $604.3M | $670M | |
Stock-Based Compensation | $9.6M | $11.3M | $10.7M | $10.2M | $10.7M | |
Change in Accounts Receivable | $7.2M | -$113.7M | -$34.3M | $46.9M | -$40.9M | |
Change in Inventories | $18.2M | -$66.2M | -$179.8M | $112.1M | $76.3M | |
Cash From Operations | $1B | -$1.1B | $977.6M | $3.5B | $1.7B | |
Capital Expenditures | $1.9B | $2B | $2.4B | $2.8B | $2.9B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.9B | -$2B | -$2.4B | -$2.8B | -$2.9B | |
Dividends Paid (Ex Special Dividend) | -$282.4M | -$323.9M | -$375.9M | -$430.3M | -$493M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $999.5M | $2.8B | $798.8M | $2.9B | $1.2B | |
Long-Term Debt Repaid | -- | -- | -$200M | -$4.2B | -$9.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$12.2M | $47.9M | $187.1M | $162M | $218.2M | |
Cash From Financing | $883.8M | $3.1B | $1.4B | -$696.8M | $1.5B | |
Beginning Cash (CF) | $24.6M | $20.8M | $116.7M | $51.6M | $19.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$3.7M | $95.9M | -$65.2M | -$32.3M | $289.6M | |
Ending Cash (CF) | $20.8M | $116.7M | $51.6M | $19.2M | $308.9M | |
Levered Free Cash Flow | -$897.7M | -$3.1B | -$1.5B | $653.8M | -$1.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $296.8M | $325M | $357.7M | $432M | $485.6M | |
Depreciation & Amoritzation | $118.6M | $133.4M | $148.3M | $165.1M | $182.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$1.6B | $578.7M | $2.7B | $746.6M | $922.9M | |
Capital Expenditures | $388.9M | $505.8M | $619.7M | $645.9M | $839.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$392.5M | -$502.2M | -$617.9M | -$644.9M | -$828.6M | |
Dividends Paid (Ex Special Dividend) | -$80.3M | -$93.5M | -$106.2M | -$121.7M | -$138.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.2B | $202.7M | $2B | -- | -- | |
Long-Term Debt Repaid | -- | -$200M | -$4.2B | -$5.7M | -$4.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9.1M | -$3.5M | -- | -- | -- | |
Cash From Financing | $2.4B | $242.1M | -$2.2B | -$123.4M | -$138.6M | |
Beginning Cash (CF) | $457.6M | $264M | $171.6M | $285.4M | $589.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $407.7M | $318.5M | -$76.4M | -$21.7M | -$44.3M | |
Ending Cash (CF) | $865.3M | $582.5M | $95.2M | $263.8M | $545.1M | |
Levered Free Cash Flow | -$1.9B | $72.8M | $2.1B | $100.7M | $83.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $697.6M | $725.3M | $829.7M | $999.6M | $1.1B | |
Depreciation & Amoritzation | $452.8M | $505.3M | $568.8M | $639.7M | $703.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$998M | $958.5M | $3.2B | $1.6B | $1.9B | |
Capital Expenditures | $1.8B | $2.3B | $2.7B | $2.8B | $3.3B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.8B | -$2.3B | -$2.7B | -$2.8B | -$3.2B | |
Dividends Paid (Ex Special Dividend) | -$301.7M | -$348.5M | -$402.7M | -$461.2M | -$525.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3B | $798.8M | $2.8B | $993.3M | $987.3M | |
Long-Term Debt Repaid | -- | -$200M | -$4.4B | -$62.7M | $233.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$18.6M | $52.1M | $189.2M | $161M | $221.1M | |
Cash From Financing | $3.3B | $1.1B | -$1.1B | $1.4B | $1.6B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $545.2M | -$282.8M | -$487.3M | $168.6M | $281.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$2.8B | -$1.4B | $560.1M | -$1.2B | -$1.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $514.4M | $574.2M | $629.5M | $743.3M | $837.4M | |
Depreciation & Amoritzation | $233.9M | $261.2M | $294.3M | $329.7M | $363.3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$1.4B | $640.5M | $2.9B | $991.9M | $1.2B | |
Capital Expenditures | $845.7M | $1.2B | $1.4B | $1.4B | $1.7B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$846.1M | -$1.2B | -$1.4B | -$1.4B | -$1.7B | |
Dividends Paid (Ex Special Dividend) | -$159.3M | -$183.9M | -$210.7M | -$241.6M | -$273.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.8B | $798.8M | $2.8B | $898.3M | $645.4M | |
Long-Term Debt Repaid | -- | -$200M | -$4.4B | -$247.7M | -$4.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$14.2M | -$9.9M | -$7.9M | -$8.9M | -$6M | |
Cash From Financing | $3.1B | $1B | -$1.4B | $661.9M | $748.8M | |
Beginning Cash (CF) | $478.4M | $380.7M | $223.2M | $304.7M | $898.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $844.5M | $465.8M | $43.6M | $244.5M | $236.3M | |
Ending Cash (CF) | $1.3B | $846.5M | $266.8M | $549.2M | $1.1B | |
Levered Free Cash Flow | -$2.2B | -$549.5M | $1.5B | -$423.7M | -$525.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.